Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Dai

Showing results (551-560 of 637) with videos related to

Pageof 64
Sort By:
Acta Pharmacologica Sinica|December 8, 2020
DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivoMeng-di Dai, Yue-Liang Wang, Jun Fan, et al.
Fitoterapia|September 18, 2025
Phenylpropanoid glycosides from the fruits of Lycium chinense and their potential anti-diabetic activityYv-Xin Fan, Yu-Guo Ma, Yan-Jie Zhu, et al.
JCI Insight|June 12, 2025
Role of progesterone action in inguinal hernia formation via skeletal muscle fibrosis and atrophyTianming You, Mehrdad Zandigohar, Tanvi Potluri, et al.
Nano-Micro Letters|July 2, 2024
Designing Symmetric Gradient Honeycomb Structures with Carbon-Coated Iron-Based Composites for High-Efficiency Microwave AbsorptionYu Zhang, Shu-Hao Yang, Yue Xin, et al.
Journal of Medicinal Chemistry|March 16, 2026
Discovery of Novel MLKL PROTAC Degraders for the Treatment of Hepatocellular Carcinoma via Promoting ParthanatosChao Chen, Kaiyuan Liu, Xinlei Wang, et al.
European Journal of Medicinal Chemistry|December 21, 2018
Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinomaQi Wang, Yang Dai, Yinchun Ji, et al.
Acta Pharmaceutica Sinica. B|March 29, 2021
Design, synthesis and biological evaluation of pyrazolo[3,4-<i>d</i>]pyridazinone derivatives as covalent FGFR inhibitorsXiaowei Wu, Mengdi Dai, Rongrong Cui, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2019
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer modelsXia Peng, Pengcong Hou, Yi Chen, et al.
Immunology|April 27, 2026
Dual Functions of Treg in the Mucosal Barrier and Lung Cancer Microenvironment and Prospects for Targeted TherapyJiaming Cui, Jingru Han, Yang Dai, et al.
World Journal of Surgery|November 22, 2013
Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasionHan Zhang, Shou-Xin Yuan, Shu-Yang Dai, et al.
Pageof 64

Showing results (551-560 of 637) with videos related to

Sort By:
Pageof 64
Acta Pharmacologica Sinica|December 8, 2020
DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivoMeng-di Dai, Yue-Liang Wang, Jun Fan, et al.
Fitoterapia|September 18, 2025
Phenylpropanoid glycosides from the fruits of Lycium chinense and their potential anti-diabetic activityYv-Xin Fan, Yu-Guo Ma, Yan-Jie Zhu, et al.
JCI Insight|June 12, 2025
Role of progesterone action in inguinal hernia formation via skeletal muscle fibrosis and atrophyTianming You, Mehrdad Zandigohar, Tanvi Potluri, et al.
Nano-Micro Letters|July 2, 2024
Designing Symmetric Gradient Honeycomb Structures with Carbon-Coated Iron-Based Composites for High-Efficiency Microwave AbsorptionYu Zhang, Shu-Hao Yang, Yue Xin, et al.
Journal of Medicinal Chemistry|March 16, 2026
Discovery of Novel MLKL PROTAC Degraders for the Treatment of Hepatocellular Carcinoma via Promoting ParthanatosChao Chen, Kaiyuan Liu, Xinlei Wang, et al.
European Journal of Medicinal Chemistry|December 21, 2018
Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinomaQi Wang, Yang Dai, Yinchun Ji, et al.
Acta Pharmaceutica Sinica. B|March 29, 2021
Design, synthesis and biological evaluation of pyrazolo[3,4-<i>d</i>]pyridazinone derivatives as covalent FGFR inhibitorsXiaowei Wu, Mengdi Dai, Rongrong Cui, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 24, 2019
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer modelsXia Peng, Pengcong Hou, Yi Chen, et al.
Immunology|April 27, 2026
Dual Functions of Treg in the Mucosal Barrier and Lung Cancer Microenvironment and Prospects for Targeted TherapyJiaming Cui, Jingru Han, Yang Dai, et al.
World Journal of Surgery|November 22, 2013
Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasionHan Zhang, Shou-Xin Yuan, Shu-Yang Dai, et al.
Pageof 64